News-Medical.Net on MSN
Study reveals how "P bodies" heavily influence a cell's fate
How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, ...
The Brighterside of News on MSN
New molecule targets and destroys harmful RNA linked to cancer and aging
Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.
"These RNAs seem to act like postal codes for gene repression," said Dr. Anuj K. Verma, lead author of the study. "They help direct the polycomb complex to precise chromatin neighborhoods where stress ...
For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
A new study identifies biliverdin reductase A (BVRA) as a crucial enzyme defending neurons from oxidative stress, acting ...
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...
A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.
AZoLifeSciences on MSN
Scientists Build the First Cellular Atlas of the World’s Deadliest Mosquito
The most dangerous animal in the world just got easier to study-and perhaps defeat one day.
November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Vir Biotechnology, Inc. today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results